Peripartum Cardiomyopathy in Nigeria Registry
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT03081949
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT03081949
-
- Main results
- Selenium supplementation in patients with peripartum cardiomyopathy: a proof-of-concept trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Nigeria
- Registry status
- Completed
Technical summary
Registry record NCT03081949. Randomized; no masking; primary purpose treatment. Start 2017-06-12 (actual); primary completion 2019-06-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Peripartum Cardiomyopathy in Nigeria Registry
- Acronym
- PEACE
- Condition
- Peripartum Cardiomyopathy
- Intervention (Drug)
- Oral Sodium Selenite 200 µg/day for 3 months
- Lead sponsor
- Aminu Kano Teaching Hospital
- Collaborator
- Nigerian Cardiac Society
Record details
- Record id
cardio:ct-nct03081949- Content hash
d3dafd13d8b1ba6b27d6a26e24b0959e48cf49c00d2656ef2b93d3b04b5d9d1e